Clear Street’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-30,000
Closed -$5K – 1688
2022
Q3
$5K Buy
+30,000
New +$27.7K ﹤0.01% 826

Clear Street's EVFM Position: Q4 2022 in Review

Clear Street sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2022, closing a stake of 30,000 shares — an estimated $5K sold.

Clear Street first reported a position in EVFM in Q3 2022 and held it in 1 quarter. The position peaked at $5K in Q3 2022. 0 funds tracked by Wall St. Rank hold EVFM as of Q4 2022.

  • Clear Street reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Clear Street sold 30,000 Evofem Biosciences, Inc. Common Stock shares in Q4 2022, an estimated $5K.
  • Clear Street first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Clear Street's Evofem Biosciences, Inc. Common Stock position peaked at $5K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2022.

Based on Clear Street's 13F filing for Q4 2022, filed 13 Feb 2023.